FutureFuels Earnings Plunge, 2026 Hopes Rest on New Plant

Futurefuel (FF), ranked by market capitalization, reported its fiscal 2025 Q4 earnings on Mar 16th, 2026, marking a stark shift from profitability to a significant loss. The company’s performance fell sharply below expectations, with a 529.4% deterioration in net income and a 67.7% revenue decline, while guidance emphasized cautious optimism for 2026 recovery through new production initiatives and regulatory clarity.

Revenue

The total revenue of Futurefuel plummeted by 67.7% to $19.84 million in 2025 Q4, a sharp decline from $61.51 million in 2024 Q4, driven by soft demand and operational challenges in both the Chemicals and Biofuels segments. The Chemicals division faced margin compression due to high input costs, while the Biofuels segment grappled with the expiration of the blenders tax credit and regulatory uncertainty.

Earnings/Net Income

Futurefuel swung to a loss of $0.27 per share in 2025 Q4 from a profit of $0.06 per share in 2024 Q4, reflecting a 529.1% negative change. The company reported a net loss of $-12.01 million, a 529.4% deterioration from the $2.80 million net income in 2024 Q4. This marked a record low for the firm, underscoring the severity of its financial pressures.

Price Action

The stock price of Futurefuel edged down 0.70% during the latest trading day, dropped 4.69% in the most recent full trading week, and surged 13.87% month-to-date, reflecting volatile investor sentiment.

Post-Earnings Price Action Review

The strategy of buying Futurefuel (FF) shares after a revenue drop quarter-over-quarter on the financial report release date and holding for 30 days resulted in a significant underperformance. The strategy had a return of -58.74%, compared to a benchmark return of 51.85%. The excess return was -110.59%, and the strategy's CAGR was -20.00%. The strategy also had a high maximum drawdown of 73.75% and a Sharpe ratio of -0.43, indicating a high risk and substantial loss.

CEO Commentary

Roeland Polet highlighted 2025 challenges, including soft demand, regulatory shifts, and high input costs, which pressured both segments. Despite a $5.6 million LIFO adjustment, the company focused on operational turnarounds, plant reliability, and backward integration via a new methacrylate plant, now fully qualified and expected to drive revenue in 2026. The Biofuels segment faced headwinds from the expired blenders tax credit and IRA 45Z uncertainty, leading to inventory reductions and production pauses. Polet expressed cautious optimism for 2026, noting improved regulatory clarity and pending growth projects.

Guidance

FutureFuel expects meaningful revenue contributions from the new methacrylate unit and expansion projects in 2026, with Biofuels resuming production as 45Z guidance stabilizes. A $0.06 per share dividend for Q1 2026 was declared, and operational performance is projected to improve post-weather-related January downtime.

Additional News

FutureFuel’s 2025 annual report detailed a $49.4 million net loss and $95.7 million in revenue, with Biofuels and Chemicals segments idling due to regulatory and market headwinds. The company advanced growth projects, including a new methacrylate plant and production line upgrades, positioning for 2026 recovery. The Biofuels segment temporarily paused production due to the expired blenders tax credit but resumed activity following IRA 45Z guidance clarity. A $0.06 dividend for Q1 2026 underscores management’s confidence in operational resilience despite ongoing cost pressures.